Browse Result
Total number of records for Atopic Dermatitis in Blood Plasma of Human in DAAB (Version-2) database: 48
| Record no | Disease | Organism | Sample | Gene Name | Techniques | Omics | Study | Comments | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Atopic Dermatitis | Human | Blood Plasma | CD5L | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput and Low Throughput | Helps in macrophage survival and binds to several cells of the immune system. | 19116453 |
| 2 | Atopic Dermatitis | Human | Blood Plasma | APOE | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput and Low Throughput | Essential component of plasma lipoproteins | 19116453 |
| 3 | Atopic Dermatitis | Human | Blood Plasma | TF | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput | Downregulated in atopic dermatitis patients | 19116453 |
| 4 | Atopic Dermatitis | Human | Blood Plasma | IGHA1 | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput | Downregulated in atopic dermatitis patients | 19116453 |
| 5 | Atopic Dermatitis | Human | Blood Plasma | FGB | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput | Downregulated in atopic dermatitis patients | 19116453 |
| 6 | Atopic Dermatitis | Human | Blood Plasma | HPX | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput | Downregulated in atopic dermatitis patients | 19116453 |
| 7 | Atopic Dermatitis | Human | Blood Plasma | HP | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput | Upregulated in atopic dermatitis patients | 19116453 |
| 8 | Atopic Dermatitis | Human | Blood Plasma | C4B | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput | Downregulated in atopic dermatitis patients | 19116453 |
| 9 | Atopic Dermatitis | Human | Blood Plasma | FGG | MALDI TOF MS and LC-MS/MS and Western Blot | Proteomics | High Throughput | Downregulated in atopic dermatitis patients | 19116453 |
| 10 | Atopic Dermatitis | Human | Blood Plasma | FGB | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is down regulated in atopic dermatitis patient. | 19116453 |
| 11 | Atopic Dermatitis | Human | Blood Plasma | TF | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is down regulated in atopic dermatitis patient. | 19116453 |
| 12 | Atopic Dermatitis | Human | Blood Plasma | FGG | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is down regulated in atopic dermatitis patient. | 19116453 |
| 13 | Atopic Dermatitis | Human | Blood Plasma | SERPINA1 | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is up regulated in atopic dermatitis patient. | 19116453 |
| 14 | Atopic Dermatitis | Human | Blood Plasma | HPX | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is down regulated in atopic dermatitis patient. | 19116453 |
| 15 | Atopic Dermatitis | Human | Blood Plasma | CD5L | 2D-PAGE and MALDI-TOF/TOF and Immunoblot | Proteomics, Others | High Throughput and Low Throughput | Upregulated level of this protein causes eosinophilia by inhibiting apoptosis or promoting the proliferation of eosinophils either in combination with or without IL5. | 19116453 |
| 16 | Atopic Dermatitis | Human | Blood Plasma | HP | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is up regulated in atopic dermatitis patient. | 19116453 |
| 17 | Atopic Dermatitis | Human | Blood Plasma | C4B | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is down regulated in atopic dermatitis patient. | 19116453 |
| 18 | Atopic Dermatitis | Human | Blood Plasma | APOE | 2D-PAGE and MALDI-TOF/TOF and Immunoblot | Proteomics, Others | High Throughput and Low Throughput | This protein is down regulated in atopic dermatitis patient. It is suggested that inflammation could impair lipoprotein metabolism and produce a wide variety of changes in the plasma concentrations of lipids and lipoproteins. | 19116453 |
| 19 | Atopic Dermatitis | Human | Blood Plasma | APOA1 | 2D-PAGE and MALDI-TOF/TOF | Proteomics | High Throughput | This protein is up regulated in atopic dermatitis patient. | 19116453 |
| 20 | Atopic Dermatitis | Human | Blood Plasma | GSN | ELISA | Others | Low Throughput | Plasma gelsolin levels were decreased in atopic dermatitis. | 26318415 |
| 21 | Atopic Dermatitis | Human | Blood Plasma | HNP1-3 | ELISA | Others | Low Throughput | Plasma alpha defensin levels are positively corelated with atopic dermatitis severity, serum IL-8 and IgE levels. | 26411782 |
| 22 | Atopic Dermatitis | Human | Blood Plasma | HNP1-3 | ELISA | Others | Low Throughput | HNP level was significantly higher in Atopic Dermatitis patients than in control subjects. | 27077833 |
| 23 | Atopic Dermatitis | Human | Blood Plasma | DCD | ELISA | Others | Low Throughput | Dermicidin was significantly higher in Atopic Dermatitis patients than in control subjects. | 27077833 |
| 24 | Atopic Dermatitis | Human | Blood Plasma | CCL17 | Bio-plex human cytokine multiplex assay | Others | High Throughput | Plasma concentration of CCL17 was higher in Atopic Dermatitis patients than in control subjects. | 27077833 |
| 25 | Atopic Dermatitis | Human | Blood Plasma | CCL22 | Bio-plex human cytokine multiplex assay | Others | High Throughput | Plasma concentration of CCL22 was higher in Atopic Dermatitis patients than in control subjects. CCL22 can serve as surrogate biomarker for monitoring disease severity in Atopic Dermatitis. | 27077833 |
| 26 | Atopic Dermatitis | Human | Blood Plasma | CCL27 | Bio-plex human cytokine multiplex assay | Others | High Throughput | Plasma concentration of CCL27 was higher in Atopic Dermatitis patients than in control subjects. CCL27 can serve as surrogate biomarker for monitoring disease severity in Atopic Dermatitis. | 27077833 |
| 27 | Atopic Dermatitis | Human | Blood Plasma | S100A12 | Planar antigen microarrays, Antigen suspension bead arrays | Others | High Throughput | IgG reactivity to S100A12 was only observed in Atopic Dermatitis patients. The antimicrobial protein S100A12 was identified as a potential autoantigen in a subgroup of Atopic Dermatitis patients. | 30728947 |
| 28 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | CCL22 | Meso Quick Plex Assay | Others | High Throughput | CCL22 was significantly up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 29 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | CCL17 | Meso Quick Plex Assay | Others | High Throughput | CCL17 was up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 30 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | IL5 | Meso Quick Plex Assay | Others | High Throughput | IL5 was significantly up regulated in blood plasma of Atopic Dermatitis patients but down regulated in stratum corneum of atopic dermatitis patients as compared to healthy controls. | 30132823 |
| 31 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | IL13 | Meso Quick Plex Assay | Others | High Throughput | IL13 was significantly up regulated in blood plasma of Atopic Dermatitis patients but down regulated in stratum corneum of atopic dermatitis patients as compared to healthy controls. | 30132823 |
| 32 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | CCL26 | Meso Quick Plex Assay | Others | High Throughput | CCL26 was significantly up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 33 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | IL4 | Meso Quick Plex Assay | Others | High Throughput | IL4 was significantly up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 34 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | CCL13 | Meso Quick Plex Assay | Others | High Throughput | CCL13 was significantly up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 35 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | GMCSF | Meso Quick Plex Assay | Others | High Throughput | GMCSF was significantly up regulated in blood plasma of Atopic Dermatitis patients but down regulated in stratum corneum of atopic dermatitis patients as compared to healthy controls. | 30132823 |
| 36 | Atopic Dermatitis | Human | Stratum Corneum, Blood Plasma | CXCL10 | Meso Quick Plex Assay | Others | High Throughput | CXCL10 was significantly down regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 37 | Atopic Dermatitis | Human | Blood Plasma | PIGF | Meso Quick Plex Assay | Others | High Throughput | PIGF was significantly up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 38 | Atopic Dermatitis | Human | Blood Plasma | TIE2 | Meso Quick Plex Assay | Others | High Throughput | Tie2 was significantly up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 39 | Atopic Dermatitis | Human | Blood Plasma | VEGFC | Meso Quick Plex Assay | Others | High Throughput | VEGFC was significantly up regulated in Atopic Dermatitis patients as compared to healthy controls. | 30132823 |
| 40 | Atopic Dermatitis | Human | Blood Plasma | IL8 | ELISA | Others | Low Throughput | IL-8 concentrations were significantly higher in severe than in mild or moderate atopic dermatitis. | 8129432 |
| 41 | Atopic Dermatitis | Human | Blood Plasma | CCL5 | ELISA | Others | Low Throughput | The mean plasma level of RANTES in patients with atopic dermatitis was significantly higher than that of normal control subjects. | 16296266 |
| 42 | Atopic Dermatitis | Human | Blood Plasma | VEGF | ELISA | Others | Low Throughput | Atopic dermatitis patients showed significantly increased VEGF plasma concentration as compared with the controls. | 22915086 |
| 43 | Atopic Dermatitis | Human | Blood Plasma | PF4 | ELISA | Others | Low Throughput | Atopic dermatitis patients showed significantly increased PF4 plasma concentration as compared with the controls. | 22915086 |
| 44 | Atopic Dermatitis | Human | Blood Plasma, Interstitial fluid | IL18 | ELISA, Luminex-based multiplex system | Others | Low Throughput, High Throughput | IL18 level was significantly higher in atopic dermatitis patients as compared to healthy controls. | 25980674 |
| 45 | Atopic Dermatitis | Human | Blood Plasma | VEGF | ELISA | Others | Low Throughput | VEGF level was significantly higher in atopic dermatitis patients as compared to healthy controls. | 25980674 |
| 46 | Atopic Dermatitis | Human | Blood Plasma, Interstitial fluid | CXCL10 | ELISA, Luminex-based multiplex system | Others | Low Throughput, High Throughput | CXCL10 level was significantly higher in atopic dermatitis patients as compared to healthy controls. | 25980674 |
| 47 | Atopic Dermatitis | Human | Blood Plasma, Interstitial fluid | CXCL9 | ELISA, Luminex-based multiplex system | Others | Low Throughput, High Throughput | CXCL9 level was significantly higher in atopic dermatitis patients as compared to healthy controls. | 25980674 |
| 48 | Atopic Dermatitis | Human | Blood Plasma, Interstitial fluid | CCL17 | ELISA, Luminex-based multiplex system | Others | Low Throughput, High Throughput | CCL17 level was significantly higher in atopic dermatitis patients as compared to healthy controls. | 25980674 |